Found 64 matching trials
Busulfan and Cyclophosphamide Followed By ALLO BMT
NAThis is a treatment guideline to allow routine clinical data to be collecte...
Location
Masonic Cancer Center, University of Minnesota
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
PHASE1This research study is assessing the feasibility of reduced intensity allog...
Location
Massachusetts General Hospital
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure
PHASE2Prognosis of patients with graft failure is dismal, and re-transplantation ...
Location
Multiple Locations
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
PHASE2RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Location
Memorial Sloan-Kettering Cancer Center
RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease
PHASE3The purpose of this clinical trial is to evaluate the clinical and cost eff...
Location
King's College Hospital
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer
PHASE2RATIONALE: Giving chemotherapy and total body irradiation before a donor bo...
Location
Memorial Sloan-Kettering Cancer Center
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NAThis study is designed to test the ability to achieve donor hematopoietic e...
Location
Masonic Cancer Center, University of Minnesota
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
PHASE1Men with progressive metastatic Castration-Resistant Prostate Cancer post f...
Location
Johns Hopkins Hospital
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
PHASE1The primary objective is to cure multiple myeloma with less toxic allogenei...
Location
Massachusetts General Hospital
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
NAStem cells collected from sibling donors for allogenic transplants contain ...
Status
Active Not Recruiting
Location
University of Alabama Hospital